Sep 26, 2015 by Brian Feroldi, Selena Maranjian, and Matt Frankel, CFPDon't Delay: Consider Making These Money Moves for Your Kids TodayThinking about giving your kids a financial leg up in life? You should consider using our tips to get the ball rolling today.
Sep 26, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Stocks We're Ready to SellWhen the market gets choppy, it can be a good time take a hard look at your portfolio.
Sep 25, 2015 by Brian FeroldiWhy bluebird bio Inc Shares Slumped AgainOn a bad day for biotech stocks, bluebird bio gets shot down.
Sep 25, 2015 by Brian FeroldiA Double Dose of Good News for Vertex Pharmaceuticals Incorporated InvestorsA European committee adopts a positive view of Vertex's drugs, and the opportunity looks huge for investors.
Sep 25, 2015 by Brian FeroldiThe Price War for New Cholesterol Drugs Is Heating UpExciting new LDL-cholesterol-lowering medication offers a lot of hope for patients with high cholesterol, but a new report says they're priced far too high to be cost-effective.
Sep 25, 2015 by Brian Feroldi, Todd Campbell, George Budwell, PhD, and Adam GalasEasy Ways to Improve Your Financial Future Right NowLooking to shore up your financial picture? Here are our top ideas that you can use to ensure a bright financial future.
Sep 25, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Mid-Cap Biotechs We're Excited AboutOur healthcare contributors think you should add these mid-cap biotechs to your watch list.
Sep 24, 2015 by Brian FeroldiKeryx Biopharmaceuticals Grabs an Important ApprovalShares of the beaten-down biopharmaceutical company bounce back on the heels of an overseas approval. What does this news mean for long term investors?
Sep 23, 2015 by Brian FeroldiWhy BioMed Realty Trust Inc is Moving Higher TodayReports that the company is looking for a buyout caused its stock to spike.
Sep 21, 2015 by Brian FeroldiDid Hillary Clinton Cause bluebird bio to Slump Today?The presidential candidate's tweet takes down the entire biotech sector, and bluebird gets caught up in the action.
Sep 21, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDHere's Why Gilead Sciences Is a Buy (Hint: It's Not Hepatitis C)Gilead's Hepatitis C treatments Sovaldi and Harvoni tend to grab all the headlines, but here are 3 other reasons that we Fools think Gilead is a top choice.
Sep 19, 2015 by Brian Feroldi3 Triple-Digit Biotech Stocks That Are Worth Every PennyAre you reluctant to invest in stocks trading for over $100? You shouldn't be. Here are three high-quality biotech names that you should consider.
Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Biotech Stocks That Can Upgrade Your PortfolioAre you looking to add some biotech exposure to your portfolio, but want to stick with the stronger names in the group? Our Motley Fool contributors have three names you should strongly consider.
Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Investing Myths, Debunked!Don't be fooled by these common stock market misconceptions
Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDOur Top Investing RegretsEverybody makes mistakes when they are investing; we Fools are no different.
Sep 18, 2015 by Brian Feroldi3 Healthcare Stocks That Cost Less Than a Trip to ChipotleA quick trip to Chipotle will set you back about $10. Instead of using that money to buy a delicious burrito, consider these tasty stocks.
Sep 18, 2015 by Brian Feroldi, Joe Tenebruso, Todd Campbell, George Budwell, PhD, and Adam Galas5 Time-Saving Investing TipsInvesting smartly can require a lot of time, but that doesn't there aren't ways to speed up the process. Here are three time-saving tips that may help you become a better investor.
Sep 16, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Healthcare Stocks That Could Add a Spark to Your PortfolioLooking to give your portfolio a jolt? Consider investing in these three spicy healthcare names.
Sep 16, 2015 by Brian Feroldi5 Reasons I'm Buying More Gilead Sciences Inc.The company gets stronger, and the price has gone nowhere. I'm back for a second helping.
Sep 15, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 MedTech Stocks to Sprinkle Into Your PortfoliosWhat medical device stocks do our contributors think could add some spice to your portfolio right now?
